Cargando…
A Single Injection of NTG-101 Reduces the Expression of Pain-Related Neurotrophins in a Canine Model of Degenerative Disc Disease
Background: Tissue sources of pain emanating from degenerative discs remains incompletely understood. Canine intervertebral discs (IVDs) were needle puncture injured, 4-weeks later injected with either phosphate-buffered saline (PBS) or NTG-101, harvested after an additional fourteen weeks and then...
Autores principales: | Matta, Ajay, Karim, Muhammad Zia, Gerami, Hoda, Benigno, Bettina Zoe, Cheng, Ivan, Mehrkens, Arne, Erwin, William Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144207/ https://www.ncbi.nlm.nih.gov/pubmed/35628530 http://dx.doi.org/10.3390/ijms23105717 |
Ejemplares similares
-
A comparative study of mesenchymal stem cell transplantation and NTG-101 molecular therapy to treat degenerative disc disease
por: Matta, Ajay, et al.
Publicado: (2021) -
NTG-101: A Novel Molecular Therapy that Halts the Progression of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2018) -
The biological basis of degenerative disc disease: proteomic and biomechanical analysis of the canine intervertebral disc
por: Erwin, William Mark, et al.
Publicado: (2015) -
Injectable Biologics for the Treatment of Degenerative Disc Disease
por: Matta, Ajay, et al.
Publicado: (2020) -
Molecular Therapy for Degenerative Disc Disease: Clues from Secretome Analysis of the Notochordal Cell-Rich Nucleus Pulposus
por: Matta, Ajay, et al.
Publicado: (2017)